Minimally invasive in tumor multidrug comparative analysis with contrast-enhanced MRI in mice.

Author: GrenleyMarc O, HattonBeryl A, KerwinWilliam S, KlinghofferRichard A, Moreno-GonzalezAlicia, ThirstrupDerek J, TretyakIlona, YouSheng

Paper Details 
Original Abstract of the Article :
To facilitate decision making in the oncology clinic, technologies have recently been developed to independently inject and assess multiple anticancer agents directly in a patient's tumor. To increase the flexibility of this approach beyond histological readouts of response, contrast-enhanced MRI wa...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/mrm.25978

データ提供:米国国立医学図書館(NLM)

Minimally Invasive Multidrug Analysis with Contrast-Enhanced MRI in Mice

This study focuses on the development of new technologies for evaluating the effectiveness of multiple anticancer drugs directly within tumors. The researchers, like innovative engineers constructing cutting-edge tools, explore the use of contrast-enhanced MRI to assess drug efficacy in a minimally invasive manner. This research, like a meticulously designed experiment in a desert laboratory, seeks to improve the accuracy and efficiency of cancer treatment.

MRI-Based Multidrug Assessment: A New Frontier in Cancer Research

The study demonstrates the potential of contrast-enhanced MRI as a tool for evaluating the response of tumors to multiple anticancer drugs. This research, like a beacon of hope in the relentless fight against cancer, offers a glimpse into the future of personalized medicine, where treatment strategies are tailored to the specific needs of each patient.

Improving Cancer Treatment through Innovative Technologies

This study underscores the importance of developing innovative technologies for improving cancer diagnosis and treatment. This research, like a well-forged weapon in the battle against cancer, provides valuable insights into the potential of MRI-based multidrug assessment for optimizing cancer therapy.

Dr.Camel's Conclusion

This research, like a desert caravan carrying precious cargo, brings us closer to a future where cancer treatment is more precise, effective, and personalized. The authors' innovative approach to multidrug assessment holds great promise for improving patient outcomes and enhancing our understanding of cancer biology.

Date :
  1. Date Completed 2017-12-18
  2. Date Revised 2018-02-16
Further Info :

Pubmed ID

26362018

DOI: Digital Object Identifier

10.1002/mrm.25978

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.